
Sign up to save your podcasts
Or


In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
By American Academy of Neurology4.7
1919 ratings
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.

321 Listeners

501 Listeners

302 Listeners

49 Listeners

883 Listeners

12 Listeners

21 Listeners

91 Listeners

517 Listeners

133 Listeners

363 Listeners

182 Listeners

373 Listeners

6 Listeners

80 Listeners